Obesity — Study of a Holistic Health Program for United Methodist Clergy
Citation(s)
Alberti KG, Zimmet P, Shaw J Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006 May;23(5):469-80. Review.
Halaas GW Ministerial health and wellness, 2002, Evangelical Lutheran Church in America. Chicago, IL; 2002.
Jones SH, Francis LJ, Jackson C The relationship between religion and anxiety: a study among Anglican clergymen and clergywomen. Journal of Psychology & Theology. 2004;32(2):137-42.
Knox S, Virginia SG, Lombardo J Depression and anxiety in Roman Catholic secular clergy. Pastoral Psychology. 2002;50:345-58.
Knox S, Virginia SG, Smith J Pilot study of psychopathology among Roman Catholic secular clergy. Pastoral Psychology. 2007;55(297-306).
Knox S, Virginia SG, Thull J, Lombardo JP Depression and contributors to vocational satisfaction in Roman Catholic secular clergy. Pastoral Psychology. 2005;54(139-153).
Morris ML, Blanton PW The influence of work-related stressors on clergy husbands and their wives. Family Relations. 1994;43(2):189-95.
Proeschold-Bell RJ, LeGrand SH High rates of obesity and chronic disease among United Methodist clergy. Obesity (Silver Spring). 2010 Sep;18(9):1867-70. doi: 10.1038/oby.2010.102. Epub 2010 May 6.
A Randomized Multiple Baseline Intervention Study of Metabolic Syndrome, Mental Health, and Spiritual Well-Being of United Methodist Clergy in North Carolina
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
